AstraZeneca appoints new China head

The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
AstraZeneca PLC AZN shares dropped 2.87% to £104.80 Wednesday, on what proved to be an all-around rough trading session for ...
Enhertu won its initial China nod in early 2023 as a treatment for previously treated HER2-positive breast cancer and later ...
The UK's benchmark FTSE 100 fell on Wednesday, ending a five-day winning streak, dragged by AstraZeneca's decline on target ...
AstraZeneca (AZN) announced the appointment of Iskra Reic as Executive Vice President, International with responsibility for overall strategy ...
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on beh ...
British pharmaceutical giant AstraZeneca on Wednesday named Iskra Reic as its new international executive vice president, replacing Leon Wang, who has been detained by Chinese authorities. Reic will ...
The breast cancer drug Enhertu will be added to China’s national health insurance scheme beginning in the new year — despite ...
AstraZeneca (GB:AZN) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now At ...
Once a common sight among the trees, many of Japan's bear hunters are now older, and their numbers are dwindling. As the ...